Technology-Enabled Skin Cancer Screening for Stem Cell Transplant Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial studies the impact of educating stem cell transplant patients and their doctors on early detection of skin cancer. Patients receive information on how to check their skin and periodic reminders, while doctors get training and tools to better identify suspicious spots. The goal is to catch skin cancer early when it is easier to treat.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Is technology-enabled skin cancer screening safe for stem cell transplant survivors?
How does the Technology-Enabled Skin Cancer Screening treatment differ from other treatments for skin cancer in stem cell transplant survivors?
This treatment is unique because it focuses on increasing skin cancer screening rates through educational interventions for both patients and their doctors, rather than directly treating the cancer itself. It aims to identify and overcome barriers to regular screening, which is crucial for early detection and reducing cancer-related health issues in stem cell transplant survivors.13567
What data supports the effectiveness of this treatment for skin cancer screening in stem cell transplant survivors?
The study 'Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors' suggests that using technology to activate both patients and physicians can increase skin cancer screening rates among transplant survivors, who are at high risk for skin cancer. Additionally, the 'Skin cancer screening after solid organ transplantation' study highlights the importance of having a screening policy and education to improve adherence to screening practices, which can be relevant to the effectiveness of the treatment in increasing screening rates.158910
Who Is on the Research Team?
Saro H Armenian
Principal Investigator
City of Hope Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for stem cell transplant survivors who are 2-5 years post-transplant, can read and write in English or Spanish, have seen a primary care provider recently or plan to within a year, and can receive text messages. Those with active cancer or acute illness that limits participation cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a study packet on skin cancer and text messages every 3 weeks for 9 months. Physicians may receive additional educational materials and tools.
Follow-up
Participants are monitored for changes in skin cancer screening practices and health promotion activities.
What Are the Treatments Tested in This Trial?
Interventions
- Computer-Assisted Intervention
- Dermatoscope
- Educational Intervention
- Educational Intervention (Physician)
- Questionnaire Administration
- Text Message
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator